Pacific Shuanglin Bio-pharmacy Co., LTD (000403.SZ)
CNY 22.87
(-1.04%)
CNY 22.87
(-1.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 679 Million | 524.21 Million | 408.21 Million | 194.83 Million | 190.84 Million | 116.63 Million |
| Net Income | 611.47 Million | 587.69 Million | 391.54 Million | 182.68 Million | 157.83 Million | 74.93 Million |
| Depreciation & Amortization | 145.43 Million | 126.38 Million | 115.75 Million | 47.36 Million | 46.3 Million | 49.02 Million |
| Deferred income taxes | -6.7 Million | -27.93 Million | -3.85 Million | -1.07 Million | -663.41 Thousand | -277.51 Thousand |
| Stock-based compensation | 2.22 Million | 8.78 Million | 17.09 Million | 15.66 Million | - | - |
| Change in working capital | -48.73 Million | -170.54 Million | -128.65 Million | -69.6 Million | -47.33 Million | -49.25 Million |
| Other non-cash items | -41.62 Million | -1.96 Million | 16.32 Million | 19.8 Million | 34.03 Million | 41.92 Million |
| Investing Cash Flow | -289.21 Million | -556.37 Million | -678.27 Million | -302.8 Million | -29.79 Million | -10.49 Million |
| Investments in PPE | -377.26 Million | -378.64 Million | -326.15 Million | -40.17 Million | -41.11 Million | -35.01 Million |
| Acquisitions | 1.17 Million | 445.63 Thousand | -1247.00 | 86.37 Thousand | 1.31 Million | 19.52 Million |
| Investment purchases | -748.44 Million | -593 Million | -570 Million | - | - | - |
| Sales/Maturities of investments | 765.1 Million | 346.03 Million | 413.7 Million | - | - | 5 Million |
| Other Investing Activities | 69.75 Million | 68.78 Million | -195.81 Million | -262.71 Million | 10 Million | 19.52 Million |
| Financing Cash Flow | 38.23 Million | 148.46 Million | 1.05 Billion | 96.66 Million | -204.77 Million | -67.34 Million |
| Debt repayment | -131.24 Million | -255.32 Million | -821.73 Million | -235 Million | -70 Million | -74 Million |
| Dividends payments | -58.61 Million | -41.04 Million | -140.53 Thousand | -32.84 Million | -144.6 Million | -23.27 Million |
| Common Stock Repurchased | -24.23 Million | -21.97 Million | 1.26 Million | -1.76 Million | - | - |
| Common Stock Issuance | - | 21.97 Million | -1.26 Million | 35.19 Million | - | - |
| Other Financing Activities | -26.22 Million | 453.44 Million | 1.88 Billion | 477.06 Million | 9.83 Million | 29.92 Million |
| Accounts receivables | 274.65 Million | -329.06 Million | -196.57 Million | -89.04 Million | -125.83 Million | -18.2 Million |
| Accounts payables | -31.25 Million | 70.94 Million | 70.06 Million | 57.62 Million | 96.38 Million | -20.39 Million |
| Inventory | -285.42 Million | 115.51 Million | 1.71 Million | -37.1 Million | -17.21 Million | -10.37 Million |
| Other working capital | 2.22 Million | -27.93 Million | -3.85 Million | -1.07 Million | -663.41 Thousand | -38.88 Million |
| Cash at beginning of period | 1 Billion | 885.15 Million | 99.63 Million | 110.94 Million | 154.66 Million | 115.87 Million |
| Cash at end of period | 1.42 Billion | 1 Billion | 885.15 Million | 99.63 Million | 110.94 Million | 154.66 Million |
| Capital Expenditure | -377.26 Million | -378.64 Million | -326.15 Million | -40.17 Million | -41.11 Million | -35.01 Million |
| Effect of forex changes on cash | -23.42 Thousand | -1.18 Million | -228.45 Thousand | 1.59 | - | - |
| Net cash flow / Change in cash | 428 Million | 115.11 Million | 785.52 Million | -11.3 Million | -43.72 Million | 38.79 Million |
| Free Cash Flow | 301.73 Million | 145.57 Million | 82.05 Million | 154.66 Million | 149.73 Million | 81.61 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 205.03 Million | 121.94 Million | 285.91 Million | 611.47 Million | 183.05 Million | 86.76 Million |
| Depreciation & Amortization | 34.23 Million | 34.23 Million | 142.74 Million | 145.43 Million | -68.43 Million | 35.94 Million |
| Deferred income taxes | - | - | - | -6.7 Million | 128.72 Million | -134.06 Million |
| Stock-based compensation | - | - | 2.22 Million | 2.22 Million | -2.22 Million | 2.22 Million |
| Change in working capital | -177.84 Million | - | -8.54 Million | -48.73 Million | -19.86 Million | 19.86 Million |
| Other non-cash items | 35.51 Million | -173.81 Million | 30.92 Million | -41.62 Million | -151.63 Million | 39.09 Million |
| Investing Cash Flow | -182.62 Million | -440.37 Million | 183.5 Million | -289.21 Million | -135.4 Million | -165.63 Million |
| Investments in PPE | -78.62 Million | -111.4 Million | -73.51 Million | -377.26 Million | -86.22 Million | -115.73 Million |
| Acquisitions | 53.87 Thousand | 10.02 Thousand | 467.06 Thousand | 1.17 Million | 7844.66 | 701 Thousand |
| Investment purchases | -640 Million | -510.86 Million | -50.44 Million | -748.44 Million | -258 Million | -240 Million |
| Sales/Maturities of investments | 550 Million | 167.83 Million | 292.81 Million | 765.1 Million | 190.9 Million | 151.26 Million |
| Other Investing Activities | -14.05 Million | 14.05 Million | 13 Million | 69.75 Million | 17.91 Million | 38.13 Million |
| Financing Cash Flow | -161.85 Million | 51.59 Million | 9.78 Million | 38.23 Million | -41.39 Million | 31.74 Million |
| Debt repayment | -24.44 Million | -56.27 Million | -13.1 Million | -131.24 Million | -84.1 Million | -99.2 Million |
| Dividends payments | -149.46 Million | -3.01 Million | -2.09 Million | -58.61 Million | -61.18 Million | -1.16 Million |
| Common Stock Repurchased | - | - | -24.23 Million | -24.23 Million | 24.24 Million | -24.24 Million |
| Common Stock Issuance | - | - | - | - | -24.24 Million | 24.24 Million |
| Other Financing Activities | -133.58 Million | -1.66 Million | -1.23 Million | -26.22 Million | 103.89 Million | 132.11 Million |
| Accounts receivables | 52.42 Million | - | 274.65 Million | 274.65 Million | -286.96 Million | 286.96 Million |
| Accounts payables | - | - | - | -31.25 Million | 2.22 Million | -2.22 Million |
| Inventory | -230.26 Million | - | -285.42 Million | -285.42 Million | 267.09 Million | -267.09 Million |
| Other working capital | - | - | 2.22 Million | 2.22 Million | -2.22 Million | 2.22 Million |
| Cash at beginning of period | 988.5 Million | 1.42 Billion | 782.07 Million | 1 Billion | 889.27 Million | 973.23 Million |
| Cash at end of period | 850.34 Million | 987.64 Million | 1.42 Billion | 1.42 Billion | 782.07 Million | 889.27 Million |
| Capital Expenditure | -78.62 Million | -111.4 Million | -73.51 Million | -377.26 Million | -86.22 Million | -115.73 Million |
| Effect of forex changes on cash | 9850.89 | 3817.82 | -88.04 Thousand | -23.42 Thousand | -13.81 Thousand | 106.32 Thousand |
| Net cash flow / Change in cash | -138.15 Million | -440.63 Million | 646.2 Million | 428 Million | -107.19 Million | -83.96 Million |
| Free Cash Flow | 127.68 Million | -163.27 Million | 379.75 Million | 301.73 Million | -16.61 Million | -65.91 Million |
RFAI
2754
IRM
0HGV
ORLA
CVPUF